Eli Lilly is voluntarily recalling 1 lot of Glucagon® Emergency Kit for Low Blood Sugar to the consumer/user level due to a product complaint reporting that the vial of Glucagon was in liquid form instead of powder form.
Glucagon Emergency Kit is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus. It is also approved as a diagnostic aid for use during radiologic examination to temporarily inhibit movement of the gastrointestinal tract in adult patients. The kit includes a single-dose vial containing 1mg of Glucagon as a lyophilized powder and a prefilled syringe with diluent.
According to the Company, a manufacturing issue may have resulted in the liquid appearing in the vial of Glucagon. Use of the affected product may fail to treat patients with severe hypoglycemia due to a loss of potency.
To date, the Company has received 1 product complaint in which the patient reported a lack of drug effect along with subsequent seizures. The recalled lot of Glucagon Emergency Kit for Low Blood Sugar; Lot Number D239382D; Expiration Date April 2022, was distributed nationwide to wholesalers and retailers.
Consumers with any product or recall related questions may contact The Lilly Answers Center at (800) 545-5979.
Adverse events or quality issues should be reported to the Food and Drug Administration’s MedWatch Adverse Event Reporting program.
Eli Lilly and Company issues voluntary nationwide recall of one lot of Glucagon® emergency kit due to loss of potency. News release. Eli Lilly and Company. Accessed September 27, 2021. https://www.prnewswire.com/news-releases/eli-lilly-and-company-issues-voluntary-nationwide-recall-of-one-lot-of-glucagon-emergency-kit-due-to-loss-of-potency-301385033.html.
This article originally appeared on MPR